基于 1 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
无可用的信号评分。
Explore the complete record of transactions filed by Huber Martin H. Jr., 董事. Insider active across 3 companies, notably Syndax Pharmaceuticals Inc. Cumulatively, 11 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €40k. Activity tracked since 2 February 2022. The latest transaction was disclosed on 4 February 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 条申报中的 11 条
Huber Martin H. Jr. is Administrateur and has 11 filings in total. Across the 11 sampled filings, they cover the period from 2022-02-03 to 2026-02-06, with EUR 40014 of buys and EUR 0 of sells, and the dominant transaction nature is Attribution.